Here's how you can reach us...
  • Tel:
  • Email:

Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) Technology

Inquiry

Unique higher-order structures (HOS) and conformational dynamics are critical to the function and safety of protein therapeutics, requiring fast and reliable analytical methods to fully characterize them. At CD Formulation, we combine hydrogen-deuterium exchange (HDX) with mass spectrometry (MS) and integrate them into our advanced protein characterization platform to study conformational changes of proteins upon binding to different ligands, at different pH or temperature conditions. Our goal is to provide unique solutions to challenging problems encountered in protein therapeutic discovery and development.

What is HDE-MS Technology?

HDX-MS is a powerful biophysical technique used to study the structural dynamics of proteins and protein complexes. The technique exploits the labile nature of protons present on protein backbone amides and involves monitoring the exchange of hydrogen atoms with deuterium atoms when a protein sample is exposed to a deuterated solvent. Amide hydrogens on the biomolecule backbone exchange with deuterium in solution at different rates, which are somewhat conformation-dependent and can be used to infer information about protein structure and conformation. Coupled with MS, it can be used to measure the rate of deuterium uptake. The technique has few limitations in terms of protein size, flexibility or reaction conditions and can be performed in solution at different pH and temperature under controlled redox conditions.

Fig. 1 Basic principle of HDX-MS.Fig. 1 Basic principle and methodology of HDX-MS. (Deng B, et al., 2016)

Our Services Related to HDX-MS

Thanks to decades of experience in supporting protein/peptide biopharmaceutical development and manufacturing using HDX-MS technology, our team of highly qualified experts offers a range of HDX-MS-related services to accelerate the implementation and success of your projects.

Our scientists will work with you to continuously optimize HDX-MS programs to support all stages of protein/peptide drug development and manufacturing - from early protein/peptide drug discovery to late-stage drug development and post-release testing under GMP.

Utilizing cutting-edge HDX-MS technology, we support the following protein/peptide characterization plans, including but not limited to:

Protein Conformation Analysis

The correct conformation of a protein is a key factor in ensuring its normal function. Our scientists use HDX-MS technology to analyze the key structural features and dynamic properties of proteins, including tertiary and quaternary structures.

Antibody Epitope Mapping

Epitope mapping is a critical step in the development of therapeutic antibodies and vaccines, especially during the lead-generation phase of drug discovery. Both the FDA and EMEA recommend epitope mapping as a tool to uncover information about specific binding sites in therapeutic antibodies. Our scientists use HDX-MS to perform epitope mapping to support the development of drug candidates and to assess immune responses elicited by vaccines or other therapies.

Protein Aggregation Characterization

The stability of aggregation affects the rate of hydrogen-deuterium exchange. Aggregates are more stable and the exchange rate of hydrogen atoms is usually slower. Our scientists compare the hydrogen-deuterium exchange patterns of monomers and aggregates to identify conformational changes, including changes in α-helices and β-folds, so as to study the kinetics of protein aggregation under different conditions, such as pH, salt concentration, temperature changes, etc.

In addition to the key plans mentioned above, we also use HDX-MS technology to support the following studies, including but not limited to:

  • Protein-protein interaction studies
  • Exploring the structure-function relationship between glycan structure and protein folding energy.
  • Evaluating the dynamic comparability between innovator drugs and biosimilar candidates.

Our Procedure for HDX-MS Analysis

At CD Formulation, we offer the following two HDX-MS protocols, including:

Local/Bottom-up HDX-MS

The most common strategy for this technology involves in-solution labeling and enzymatic digestion of proteins into peptides, which are then analyzed using mass spectrometry. This ensures complete sequence coverage and captures specific region information from the protein.

Typical workflow includes:

  • Labeling: Incubate the protein sample in D2O buffer to allow H/D exchange (10 seconds to several hours).
  • Quenching: Reduce pH and temperature to prevent further exchange or back exchange.
  • Digestion: Digest the protein with a suitable protease into shorter peptides for analysis.
  • LC-MS analysis: The mass spectrometer analyzes the peptides, producing a set of LC-MS chromatograms corresponding to the peptide groups at different labeling times.
  • Data processing: Use data analysis software to determine the uptake/incorporation of deuterium in the digested peptides and plot graphs at multiple time points.

Fig. 2 Local or bottom-up HDX-MS.Fig. 2 Workflow for local or bottom-up HDX-MS. (CD Formulation)

Native / Up-bottom HDX-MS

This protocol is an alternative to bottom-up HDX-MS.

In intact/up-down HDX-MS, proteins are introduced to the mass spectrometer after deuterium exchange without any enzymatic digestion. This technique allows the measurement of deuterium uptake at the intact level.

Advantages of Our HDX-MS Technology

  • High efficiency: HDX-MS experiments can usually be completed in weeks, while structure determination by X-ray crystallography or NMR may take months.
  • High sensitivity and accuracy: Allows accurate characterization of proteins with different molecular weights from ~10 kDa to ~2MDa.
  • High resolution: HDX-MS technology can reveal protein conformational dynamics over a wide range of time scales, providing detailed information about protein folding, surface accessibility, and even conformational changes when binding to targets.
  • Low sample volume required: HDX-MS requires only 0.1 mg of protein, far less than X-ray crystallography or NMR.
  • No size limit: Unlike NMR, there is no theoretical size limit for proteins analyzed by HDX-MS, which makes it ideal for studying large biomolecular complexes such as membrane proteins.
  • No chemical labeling required: HDX-MS does not require additional chemical labels, such as isotope labeling required for NMR.

Custom HDX-MS Services

Higher-Order Structures (HOS) Proteins & Peptides Characterization

The ICH Q6B Guide for Biologics Test Procedures and Acceptance Criteria states that HOS characterization is a key component in defining the critical quality attributes (CQAs) of a protein or peptide. Using our cutting-edge HDX-MS technology to obtain HOS data on proteins and peptides to guide your subsequent formulation development, process development, stability studies, etc.

Proteins & Peptides Particle and Aggregation Characterization

Protein aggregation and particle characterization help assess the extent of protein degradation, stability, and aggregate formation in solution. We use HDX-MS microscopy analysis technology to characterize protein/peptide aggregation to in-depth understanding of the agglomeration of the product in the development and manufacturing process, thereby helping you optimize the manufacturing process.

Proteins & Peptides Comparability Studies

Comparability studies are key to ensuring that changes in manufacturing processes or formulation conditions don't adversely affect the quality, safety, and efficacy of protein/peptide therapeutic products. We use HDX-MS technology to perform conformational comparability studies of protein/peptide therapeutic products according to the principles of the ICH Q5E guideline.

Proteins & Peptides Biosimilarity Studies

Biosimilarity studies, a key step to ensure the similarity between biosimilars and reference or original drugs, are also important for regulatory agencies to approve biosimilars for marketing. We use HDX-MS technology to perform conformational biosimilarity studies to demonstrate changes in critical quality attributes (CQAs) of protein/peptide biosimilar products, providing highly relevant early characterization and later comparative data.

Why Choose Our HDX-MS Technology?

  • Our team of experienced professionals with extensive knowledge in mass spectrometry and structural biology ensures high-quality services and accurate results.
  • We have accumulated decades of expertise and successful project experience using HDX-MS technology to support protein/peptide biopharmaceutical development.
  • We utilize state-of-the-art HDX-MS instrumentation that allows for high sensitivity and resolution, leading to better-quality data.
  • Our services offer a wide range of applications, from studying protein conformational dynamics to understanding protein-ligand interactions and protein-protein interactions.
  • We provide customized experimental designs to meet the specific needs of your research project, ensuring the collection of relevant and meaningful data.
  • We not only provide raw data but also comprehensive analysis and interpretation support to help you understand the meaning of your results.
  • We have a strong track record of success, with many satisfied customers benefiting from our HDX-MS services.

Publication

Published Data

Technology: Size-Exclusion Chromatography (SEC)-coupled HDX-MS.

Journal: Anal Chem.

IF: 6.7

Published: 2021

Results:

The authors developed a method to integrate SEC into the classic bottom-up HDX-MS workflow to efficiently clean up samples or enrich target proteins online under quenching conditions before reversed-phase separation and MS analysis. Angiotensin II bradykinin was selected as a model protein to demonstrate the feasibility of the developed SEC-HDX-MS. The results showed that the SEC-coupled HDX-MS method allows the analysis to be completed with lower or similar back exchange compared to traditional experiments. This method is suitable for efficient online removal of lipid components from protein-lipid systems, removal of antibodies from antigens during epitope mapping, and elimination of MS interfering compounds during HDX-MS analysis of disulfide-bonded proteins.

Fig. 3 Two SEC–HDX-MS configurations for bottom-up analysis.Fig. 3 Schematic illustrations of the two SEC–HDX-MS configurations for bottom-up analysis. (Calvaresi V, et al., 2021)

CD Formulation aims to provide a powerful analytical tool for protein/peptide HOS and conformational dynamics characterization. Please feel free to contact us if you are interested in our services. Learn how our HDX-MS technology can support the smooth implementation of your protein/peptide biopharmaceutical program.

References

  1. Ozohanics O, Ambrus A. Hydrogen-Deuterium Exchange Mass Spectrometry: A Novel Structural Biology Approach to Structure, Dynamics and Interactions of Proteins and Their Complexes. Life (Basel). 2020,10(11):286.
  2. Wei H, Mo J, Tao L, et al. Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discov Today. 2014, 19(1):95-102.
  3. Deng B, Lento C, Wilson DJ. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review. Anal Chim Acta. 2016 Oct 12;940:8-20.
  4. Calvaresi V, Redsted A, Norais N, et al. Hydrogen-Deuterium Exchange Mass Spectrometry with Integrated Size-Exclusion Chromatography for Analysis of Complex Protein Samples. Anal Chem. 2021 Aug 24;93(33):11406-11414.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services

CD Formulation is an expert in formulation science and pharmaceutical process development in therapeutic proteins & peptides, dedicated to supporting biotherapeutics development and production...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.